• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Egalet to Host Conference Call and Webcast to Discuss Third Quarter 2016 Financial Results

    Chelsea Pratt
    Oct. 20, 2016 04:20AM PST
    Life Science Investing News

    Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that its third quarter financial results will be released on Friday, November 4, 2016.

    Egalet Corporation (EGLT) (“Egalet”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that its third quarter financial results will be released on Friday, November 4, 2016.  Following the announcement, Egalet’s management will host a live conference call and webcast at 8:30 a.m. Eastern Time to review the company’s financial and operating results and provide a general business update.
    Interested parties may listen to the call via a live audio webcast which may be accessed by visiting Egalet’s website. Please connect to the website a few minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Individuals also may participate in the call by dialing 1-888-346-2615 (domestic) or 1-412-902-4253 (international) and asking for the “Egalet Earnings Call.”  The replay will be available approximately two hours after the call on the Egalet website.
    About Egalet
    Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has two approved products: OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray. In addition, using its proprietary Guardian™ Technology, Egalet is developing a pipeline of clinical-stage, product candidates that are specifically designed to deter abuse by physical and chemical manipulation. The lead programs, ARYMO™ ER, an abuse-deterrent, extended-release, oral morphine formulation, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation, are being developed for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Egalet’s Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles. For additional information on Egalet, please visit egalet.com. For full prescribing information on SPRIX, including the boxed warning, please visit sprix.com. For full prescribing information on OXAYDO, please visit oxaydo.com.
    Investor and Media Contact:
    E. Blair Clark-Schoeb
    Senior Vice President, Communications
    Email: bcs@egalet.com
    Tel: 917-432-9275
    Logo – https://photos.prnewswire.com/prnh/20140219/NY67493LOGO
    To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/egalet-to-host-conference-call-and-webcast-to-discuss-third-quarter-2016-financial-results-on-november-4-2016-300347802.html
    SOURCE Egalet Corporation

    Related Links

    https://www.egalet.com

    specialty pharmaceuticalpharmaceutical productsfinancial resultsconference callpharmaceutical ingredientsproduct candidates
    The Conversation (0)

    Go Deeper

    AI Powered

    Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

    AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF SECOND QUARTER 2025 RESULTS AND CONFERENCE CALL

    AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF SECOND QUARTER 2025 RESULTS AND CONFERENCE CALL

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×